Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat vs EPO for Sarcopenia in Hemodialysis Patients
NCT07162090Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of roxadustat in Sarcopenia, anemia of chronic kidney disease (CKD-A), sponsored by Tianjin Medical University General Hospital. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
roxadustat
03
Conditions
Sarcopeniaanemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT07162090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07162090.